- Investing Ideas
- /
- Hong Kong Undervalued Stocks Based On Cash Flows
Hong Kong Undervalued Stocks Based On Cash Flows
Results
39
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
39 companies
Innovent Biologics
Market Cap: HK$78.2b
A biopharmaceutical company, develops and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in the People’s Republic of China.
1801
HK$47.75
7D
-5.0%
1Y
27.8%
EDA Group Holdings
Market Cap: HK$1.1b
Provides e-commerce supply chain solutions in the People’s Republic of China, the United States, Canada, the United Kingdom, Germany, and Australia.
2505
HK$2.59
7D
-9.8%
1Y
n/a
Genscript Biotech
Market Cap: HK$22.5b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$10.42
7D
-14.6%
1Y
-18.3%
Maoyan Entertainment
Market Cap: HK$7.8b
An investment holding company, operates a platform in the entertainment industry in the People’s Republic of China.
1896
HK$6.75
7D
-8.9%
1Y
-31.7%
Tianneng Power International
Market Cap: HK$6.8b
An investment holding company, engages in the research, development, manufacture, and sale of power batteries for electric vehicle market in the People’s Republic of China and internationally.
819
HK$6.02
7D
-10.8%
1Y
-3.8%
China Ruyi Holdings
Market Cap: HK$35.6b
An investment holding company, engages in content production and online streaming business in the People's Republic of China, Hong Kong, Europe, and internationally.
136
HK$2.30
7D
-2.1%
1Y
25.7%
Zhejiang Leapmotor Technology
Market Cap: HK$67.3b
Engages in the research and development, production, and sale of new energy vehicles (EVs) in Mainland China and internationally.
9863
HK$50.35
7D
-9.2%
1Y
97.1%
Beijing Chunlizhengda Medical Instruments
Market Cap: HK$5.0b
Beijing Chunlizhengda Medical Instruments Co., Ltd.
1858
HK$9.14
7D
-9.5%
1Y
-8.4%
RemeGen
Market Cap: HK$22.7b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.
9995
HK$28.60
7D
7.9%
1Y
-11.3%
Plover Bay Technologies
Market Cap: HK$5.4b
An investment holding company, designs, develops, and markets software defined wide area network routers.
1523
HK$4.88
7D
-16.0%
1Y
78.1%
Binjiang Service Group
Market Cap: HK$6.6b
Provides property management and related services in the People’s Republic of China.
3316
HK$23.70
7D
-4.8%
1Y
38.3%
BYD Electronic (International)
Market Cap: HK$74.2b
An investment holding company, primarily engages in the design, manufacture, assembly, and sale of mobile handset components, modules, and other products in the People’s Republic of China and internationally.
285
HK$32.95
7D
-11.2%
1Y
22.9%
Shanghai Chicmax Cosmetic
Market Cap: HK$19.9b
A multi-brand cosmetics company, engages in the research, development, manufacture, and sale of cosmetics products in Mainland China and internationally.
2145
HK$50.00
7D
-0.5%
1Y
7.0%
Linklogis
Market Cap: HK$2.1b
An investment holding company, provides supply chain finance technology and data-driven emerging solutions in Mainland China.
9959
HK$1.06
7D
-19.7%
1Y
-28.4%
CSC Financial
Market Cap: HK$175.0b
Provides investment banking services in Mainland China and internationally.
6066
HK$8.55
7D
-11.8%
1Y
52.4%
J&T Global Express
Market Cap: HK$52.6b
An investment holding company, offers integrated express delivery services in the People’s Republic of China, Indonesia, the Philippines, Malaysia, Thailand, Vietnam, Saudi Arabia, the United Arab Emirates, Mexico, Brazil, and Egypt.
1519
HK$5.31
7D
-2.7%
1Y
-50.2%
JS Global Lifestyle
Market Cap: HK$5.7b
Engages in the research and development, design, production, marketing, distribution, and sale of small household appliances in Mainland China, North America, Europe, and internationally.
1691
HK$1.65
7D
-11.8%
1Y
14.6%
Bosideng International Holdings
Market Cap: HK$44.6b
Engages in the apparel business in the People’s Republic of China.
3998
HK$3.89
7D
-3.0%
1Y
-1.5%
Akeso
Market Cap: HK$73.8b
A biopharmaceutical company, researches, develops, manufactures, and commercializes antibody drugs.
9926
HK$82.20
7D
-4.3%
1Y
66.1%
Giant Biogene Holding
Market Cap: HK$70.4b
An investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People’s Republic of China.
2367
HK$69.20
7D
-3.1%
1Y
58.0%
MicroPort NeuroScientific
Market Cap: HK$5.7b
Engages in the research and development, production, and sale of neuro-interventional medical devices in the People’s Republic of China and internationally.
2172
HK$9.97
7D
-9.5%
1Y
18.8%
BYD
Market Cap: HK$1.1t
Engages in automobiles and batteries business in the People’s Republic of China, Hong Kong, Macau, Taiwan, and internationally.
1211
HK$368.80
7D
-1.6%
1Y
75.5%
Intron Technology Holdings
Market Cap: HK$1.4b
An investment holding company, operates as an automotive electronics solutions provider in Hong Kong, the Mainland China, and internationally.
1760
HK$1.27
7D
-5.2%
1Y
-34.2%
Zhaojin Mining Industry
Market Cap: HK$59.7b
An investment holding company, engages in exploration, mining, processing, smelting, and sale of gold and other metallic products in the People’s Republic of China.
1818
HK$16.86
7D
12.0%
1Y
15.3%
Super Hi International Holding
Market Cap: HK$10.0b
An investment holding company, operates Haidilao branded Chinese cuisine restaurants in Asia, North America, and internationally.
9658
HK$15.32
7D
-14.3%
1Y
2.1%
WEILONG Delicious Global Holdings
Market Cap: HK$37.9b
Weilong Delicious Global Holdings Ltd. produces and sells spicy snack food.
9985
HK$16.10
7D
0.9%
1Y
182.5%
Xiaomi
Market Cap: HK$1.1t
An investment holding company, provides hardware and software services in Mainland China and internationally.
1810
HK$44.25
7D
-3.6%
1Y
168.2%
Q Technology (Group)
Market Cap: HK$7.5b
An investment holding company, engages in the design, research and development, manufacturing, and sale of camera and fingerprint recognition modules in the Mainland of China, Hong Kong, India, and internationally.
1478
HK$6.22
7D
-11.5%
1Y
82.9%
MicroPort Scientific
Market Cap: HK$12.7b
An investment holding company, engages in the manufacture, marketing, and sale of medical devices in the People’s Republic of China, North America, Europe, rest of Asia, South America, and internationally.
853
HK$6.86
7D
-11.3%
1Y
17.1%
Yeahka
Market Cap: HK$3.2b
An investment holding company, provides payment and business services to merchants and consumers in the People’s Republic of China.
9923
HK$7.05
7D
-12.1%
1Y
-34.6%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$68.6b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs to address unmet medical needs in the People’s Republic of China and internationally.
6990
HK$302.00
7D
-2.3%
1Y
107.1%
Angelalign Technology
Market Cap: HK$8.1b
An investment holding company, researches and develops, designs, manufactures, and markets clear aligner treatment solutions in the People’s Republic of China.
6699
HK$47.90
7D
-13.8%
1Y
-38.6%
DPC Dash
Market Cap: HK$12.5b
Operates a chain of fast-food restaurants in the People’s Republic of China.
1405
HK$95.50
7D
-10.2%
1Y
82.3%
Inspur Digital Enterprise Technology
Market Cap: HK$7.3b
An investment holding company, provides software development and other software services, and cloud services in the People’s Republic of China.
596
HK$6.39
7D
-7.5%
1Y
72.7%
Smoore International Holdings
Market Cap: HK$73.8b
An investment holding company, engages in the provision of vaping technology solutions.
6969
HK$11.94
7D
-6.4%
1Y
68.9%
Essex Bio-Technology
Market Cap: HK$2.4b
An investment holding company, develops, manufactures, and sells biologic drugs in the People’s Republic of China, Hong Kong, and internationally.
1061
HK$4.32
7D
4.1%
1Y
92.0%